Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Scrip, Pink Sheet
For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Scrip. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours.
Topic Drug Pricing
Pink Sheet, Scrip
For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Pink Sheet. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours.
Topic Drug Pricing
Citeline
We conducted a survey to 100 clinical trial investigators to gauge expectations for future clinical research. Your free infographic provides key insight and analysis to help you understand the future clinical trial landscape.
Topic Coronavirus Clinical Trials
Scrip, Pink Sheet
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.
Medtech Insight
For a full array of insights into how the global medtech industry is responding to the COVID-19 pandemic, turn to the quality reporting and analysis from Medtech Insight. Our expert journalists bring you the latest in your free article pack.
Topic Coronavirus
Medtech Insight
Gain your view into the global test pipeline of IVD companies developing tests to detect COVID-19 in suspected patients. Medtech Insight’s test pipeline tracker brings you essential information on the products in development and their regulatory status worldwide.
Topic Coronavirus
Scrip
A former employee of Biogen is officially charged in China for allegedly jeopardizing public health, Wuhan tests 10 million residents, India approves remdesivir.
Topic Coronavirus Vaccines
Scrip
Remdesivir shows ability to yield clinical improvement in moderately ill COVID-19 patients, but data are called ‘modest’ and shorter therapy duration showed better results than longer.
Topic Coronavirus Clinical Trials
Scrip
‘What we have to guard against is that when the streets quiet down … a lot of people are going to go back to their normal lives,’ Merck CEO Ken Frazier says in an interview with CNBC.
Topic Leadership
In Vivo
In Vivo brings you another exclusive look into the future of biopharma, medtech and healthtech with our new article pack that features interviews with rising leaders and established executives, all sharing their insight. Download your free pack for a view of how today’s rising leaders are shaping the life sciences industries of tomorrow.
Topic Leadership Medtech
In Vivo
Find out who is coming through the ranks of biopharma, medtech and healthtech organizations with In Vivo’s infographic, “30 Rising Leaders of 2020”. Your free infographic provides a snapshot view of the entrepreneurs and innovators who are moving their industries forward with creative thinking and new technologies.
Topic Leadership Medtech
Scrip
The pharmaceutical selling model will be modified even after the immediate COVID-19 pandemic crisis abates, the consulting firm ZS Associates predicts, citing new research.
Topic Coronavirus
Scrip
Roche is teaming up with Gilead on the combination trial, aiming to improve on results of remdesivir alone, which has failed to show mortality benefits in COVID-19 patients.
Topic Coronavirus
Pink Sheet
CBER Director Marks will no longer have to recuse himself from COVID-19 product reviews, a move seen as resoundingly positive by former senior FDA leaders. CDER Director Woodcock will now be free to focus solely on COVID-19 and bring her unique depth of agency experience to the Trump Administration's effort to speed development of vaccines, therapeutics and diagnostics for coronavirus.
Topic Coronavirus
Pink Sheet
Participants in a recent webinar looked at how the coronavirus is changing the way we look at clinical trials and whether new EU COVID-19 guidance might hold lessons for future approaches to study design.
Topic Coronavirus
Pink Sheet
15 May 2020
Pink Sheet
15 May 2020
Scrip
15 May 2020
Pink Sheet
15 May 2020
Pink Sheet
15 May 2020
Generics Bulletin
15 May 2020
Pink Sheet
15 May 2020
HBW Insight
15 May 2020
Pink Sheet
15 May 2020
Medtech Insight
15 May 2020
Scrip
15 May 2020
HBW Insight
15 May 2020
Scrip
15 May 2020
Medtech Insight
15 May 2020
HBW Insight
15 May 2020
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
.png)
Keep up to date